Polymeric particles conjugated with a ligand to VCAM‐1 exhibit selective, avid, and focal adhesion to sites of atherosclerosis
- 12 March 2008
- journal article
- research article
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 101 (2) , 400-407
Abstract
The increased expression of VCAM‐1 on endothelial segments within plaque regions could be used as a target to deliver polymeric drug carriers selectively to sites of atherosclerosis. We probed the hypothesis that polymeric particles conjugated with a ligand for VCAM‐1 exhibit selective and avid adhesion to sites of atherosclerosis. Particles made from polystyrene or the biodegradable polymer poly(sebacic acid)‐block‐polyethylene glycol (PSA‐PEG) were conjugated with an antibody to VCAM‐1 (α‐VCAM‐1) or IgG (negative control). The particles were injected into the jugular vein of ApoE−/− (a murine model of atherosclerosis) or wild type mice and their adhesion to the aorta determined. α‐VCAM‐1 particles exhibited significantly greater adhesion to ApoE−/− mouse aorta [32 ± 5 (mean ± SEM) particles/mm2 for polystyrene particles and 31 ± 7 particles/mm2 for PSA‐PEG particles] compared to the level of adhesion to wild type mouse aorta (18 ± 1 particles/mm2 for polystyrene particles and 6 ± 1 particles/mm2 for PSA‐PEG particles). Within ApoE−/− mice, the α‐VCAM‐1 particles exhibited significantly greater adhesion to the aorta (32 ± 5 particles/mm2 for polystyrene particles and 31 ± 7 particles/mm2 for PSA‐PEG particles) compared to the adhesion of IgG particles (1 ± 1 particles/mm2 for polystyrene particles and 2 ± 1 particles/mm2 for PSA‐PEG particles). Detailed analysis of the adhesion revealed that α‐VCAM‐1 particles exhibited focal adhesion to plaque regions, in particular the periphery of the plaques, within the ApoE−/− mouse aorta. Combined the data demonstrate that polymeric particles conjugated with a ligand to VCAM‐1 exhibit selective, avid and focal adhesion to sites of atherosclerosis providing strong evidence that VCAM‐1 ligand bearing polymeric particles could be used for targeting drugs selectively to atherosclerotic tissue. Biotechnol. Bioeng. 2008;101: 400–407.Keywords
This publication has 35 references indexed in Scilit:
- Vascular Adhesion Molecules in AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes II: effect of degradation on targeting activityBiomaterials, 2005
- Synthesis and Characterization of PEG-Based Ether−Anhydride Terpolymers: Novel Polymers for Controlled Drug DeliveryMacromolecules, 2004
- New polymeric carriers for controlled drug delivery following inhalation or injectionBiomaterials, 2002
- The N-terminal peptide of PSGL-1 can mediate adhesion to trauma-activated endothelium via P-selectin in vivoBlood, 2002
- Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytesBiomaterials, 2002
- Limited adhesion of biodegradable microspheres to E‐ and P‐selectin under flowBiotechnology and Bioengineering, 2001
- Leukocyte-endothelium adhesion molecules in atherosclerosisJournal of Laboratory and Clinical Medicine, 1998
- Endothelial Expression of a Mononuclear Leukocyte Adhesion Molecule During AtherogenesisScience, 1991
- Rheological Aspects of Thrombosis and Haemostasis: Basic Principles and ApplicationsThrombosis and Haemostasis, 1986